Physician profile
Eric D Engeron
NPI 1154328144
$4,687.44
in general payments reported to CMS, 2019-2025
26 companies · $435 in 2025
The $435 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,177 · 2020: $298 · 2021: $152 · 2022: $197 · 2023: $1,888 · 2024: $541 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,023 · Travel and Lodging: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,023.14 |
| Travel and Lodging | $841.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $1,131.11 | 2023 | |
| Inari Medical, INC. | $751.75 | 2019 | |
| Medtronic, INC. | $328.09 | 2023-2024 | Corevalve Evolut R |
| Abiomed | $270.11 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.33 | 2020-2021 | |
| Ancora Heart, INC. | $240.65 | 2023 | Accucinch |
| E.R. Squibb & Sons, L.L.C. | $160.42 | 2024-2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $149.82 | 2019-2022 | |
| Medtronic Vascular, INC. | $146.79 | 2019 | |
| Kestra Medical Technology Services, INC. | $146.12 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $141.24 | 2019-2023 | Lifevest |
| Amgen INC. | $139.17 | 2022-2024 | Repatha |
| Imperative Care, INC | $138.92 | 2023 | Symphony Catheter, Prodigy Catheter |
| Astrazeneca Pharmaceuticals Lp | $125.00 | 2023 | Farxiga |
| Itamar Medical INC | $111.78 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $109.58 | 2022-2025 | Cardiomems |
| Boston Scientific Corporation | $105.68 | 2020-2024 | Carotid Wallstent |
| Angiodynamics, INC. | $99.18 | 2025 | Angiovac |
| Daiichi Sankyo INC. | $28.65 | 2024 | Injectafer |
| Stryker Corporation | $23.03 | 2025 | Flowtriever |
| Lexicon Pharmaceuticals, INC. | $20.68 | 2023 | Inpefa |
| Pfizer INC. | $19.21 | 2019 | |
| Terumo Medical Corporation | $19.05 | 2024 | Angio-Seal |
| Scpharmaceuticals INC. | $15.39 | 2025 | |
| Shockwave Medical, INC | $14.69 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Engeron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.